Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
T134557-5mg | 5mg | In stock | $73.90 | |
T134557-10mg | 10mg | In stock | $118.90 | |
T134557-25mg | 25mg | In stock | $267.90 | |
T134557-50mg | 50mg | In stock | $380.90 | |
T134557-100mg | 100mg | In stock | $706.90 | |
T134557-200mg | 200mg | In stock | $1,272.90 |
GluN1/GluN2A-selective NMDA antagonist
Synonyms | 852918-02-6|tcn-201|TCN 201|N-(4-(2-benzoylhydrazinecarbonyl)benzyl)-3-chloro-4-fluorobenzenesulfonamide|3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulfonamide|TCN201|CHEMBL2333945|N-[[4-(benzamidocarbamoyl)phenyl]methyl]- |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | NMDA receptor antagonist selective for GluN1/GluN2A (formally NR1/NR2A) over GluN1/GluN2B (formally NR1/NR2B) containing receptors (pIC50values are 6.8 and <4.3, respectively, in human recombinant GluN1/GluN2A (formally NR1/NR2A) and GluN1/GluN2B (formal |
Storage Temp | Protected from light,Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ALLOSTERIC MODULATOR |
Mechanism of action | Allosteric modulator of GluN2A |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488194997 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488194997 |
IUPAC Name | N-[[4-(benzamidocarbamoyl)phenyl]methyl]-3-chloro-4-fluorobenzenesulfonamide |
INCHI | InChI=1S/C21H17ClFN3O4S/c22-18-12-17(10-11-19(18)23)31(29,30)24-13-14-6-8-16(9-7-14)21(28)26-25-20(27)15-4-2-1-3-5-15/h1-12,24H,13H2,(H,25,27)(H,26,28) |
InChi Key | FYIBXBFDXNPBSF-UHFFFAOYSA-N |
Canonical SMILES | C1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=C(C=C2)CNS(=O)(=O)C3=CC(=C(C=C3)F)Cl |
Isomeric SMILES | C1=CC=C(C=C1)C(=O)NNC(=O)C2=CC=C(C=C2)CNS(=O)(=O)C3=CC(=C(C=C3)F)Cl |
WGK Germany | 3 |
PubChem CID | 4787937 |
Molecular Weight | 366.46 |
PubChem CID | 4787937 |
---|---|
ChEMBL Ligand | CHEMBL2333945 |
CAS Registry No. | 852918-02-6 |
RCSB PDB Ligand | 67P |
PubChem SID | 488194997 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2328849 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328909 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328915 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328927 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328947 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328948 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328949 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328950 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328954 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328974 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328977 | Certificate of Analysis | Jan 05, 2023 | T134557 |
C2328985 | Certificate of Analysis | Jan 05, 2023 | T134557 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 46.19, Max Conc. mM: 100 |
---|---|
Sensitivity | Light sensitive;Moisture sensitive |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
Starting at $69.90
1. Bettini E, Sava A, Griffante C, Carignani C, Buson A, Capelli AM, Negri M, Andreetta F, Senar-Sancho SA, Guiral L et al.. (2010) Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptors.. J Pharmacol Exp Ther, 335 (3): (636-44). [PMID:20810618] |
2. Hansen KB, Ogden KK, Traynelis SF. (2012) Subunit-selective allosteric inhibition of glycine binding to NMDA receptors.. J Neurosci, 32 (18): (6197-208). [PMID:22553026] |